Business Consulting · Launch & Brand Strategy
Launch & Post-Launch
Diagnostic Intelligence
One integrated diagnostic. Four lenses. One story. We help pharma commercial teams turn fragmented sales, field, access, and account signals into a defensible answer on whether a launch is on track — and where to focus next.
“AI doesn't know your market. It doesn't know why Italy is behind and Spain is ahead. We do.”
01 · The moment this is built for
One integrated diagnostic. Four lenses. One story.
Every launch reaches the point where leadership asks the hard question. The data exists, owned by a dozen teams. Nobody can give a clean answer on whether it's on track.
01
Today
Fragmented
Sales, field, access, invoice, account data sit in different systems. Every QBR is a debate about whose numbers are right.
02
phamax brings
Connected & AI-ready
Domain experts harmonise and reconcile the foundation — pharma-fluent, trusted before it reaches a leadership screen.
03
Outcome
One defensible diagnostic
Leadership walks in with one agreed answer on momentum, blockers, and where to invest next.
02 · What we deliver
The four lenses of diagnostic intelligence.
We don't just 'look at the data.' We examine the launch through four specific commercial lenses to find the friction points that standard reporting missed.
Market Shaping & Referral Dynamics
Identifying where the patient funnel is leaking. Is it a lack of awareness at the community level, or a referral block at the COE?
Access & Reimbursement Velocity
Tracking the real-world time to therapy. We pinpoint regional access variances that are masked by national-level averages.
Account Penetration & Loyalty
Beyond the first script. We analyze depth of prescribing within accounts to distinguish trial-use from sustainable adoption.
Field Effectiveness & Execution
Validating whether the brand strategy is actually landing. We connect CRM activity to local performance outcomes.
One integrated diagnostic. Four lenses. One defensible answer.
03 · How we get there
The process of precision.
We don't just deliver a report. We build a governed intelligence layer that connects your siloed data into one story.
A global oncology client moved from fragmented performance review to evidence-based action — replacing 'whose numbers are right?' with 'what should we do next?'
Anonymised. Full case study on request.
01 · Connect
Foundation Work
Fragmented inputs from sales, field, access, and invoice data are harmonised into one governed intelligence layer.
02 · Examine
Structural Analysis
The launch is examined through our four diagnostic lenses, identifying momentum, blockers, and outliers in every territory.
03 · Decide
Strategic Output
Complex market signals are translated into one defensible story and territory-level recommendations for immediate action.
05 · Is this relevant to your team?
Is this relevant to your team?
01
Specialty product launched 6–24 months ago
02
Uneven uptake across markets
03
Data in separate systems
04
Upcoming leadership review needing a defensible narrative
A short conversation, not a demo. We'll tell you whether a diagnostic applies to your launch.
The first step
A short conversation — not a demo.
We'll tell you whether a diagnostic applies to your launch, or whether you just need a better dashboard.